Meeting
2018 ASCO Annual Meeting
Short, full-dose neoadjuvant chemotherapy in localized high-risk adult soft tissue sarcomas (STS): An exploratory subgroup analysis on responding patients in a randomized controlled trial comparing 3 neoadjuvant versus 3 neoadjuvant + 2 adjuvant cycles of full dose anthracycline and ifosfamide chemotherapy at a 10yr median FU.
Authors
Silvia Stacchiotti
Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Silvia Stacchiotti , Sara Pizzamiglio , Antonella Messina , Carlo Morosi , Paola Collini , Antonio Llombart-Bosch , Javier Martin Broto , Alessandro Comandone , Josefina Cruz , Giovanni Grignani , Vittorio Quagliuolo , Piero Picci , Antonino De Paoli , Angelo Paolo Dei Tos , Paolo Verderio , Paolo Giovanni Casali , Alessandro Gronchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Clinical Trial Registration Number
2004-003979-36
Citation
J Clin Oncol 36, 2018 (suppl; abstr 11558)
DOI
10.1200/JCO.2018.36.15_suppl.11558
Abstract #
11558
Poster Bd #
303
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
The real-world experience of adjuvant docetaxel and cyclophosphamide (TC) chemotherapy in HER-2 negative breast cancer.
First Author: Danilo Giffoni M. M. Mata
Poster
2020 ASCO Virtual Scientific Program
Prognostic role of % changes in longest tumor diameter (LTD) in localized high-risk soft tissue sarcoma (STS) treated with neoadjuvant chemotherapy in a randomized clinical trial.
First Author: Silvia Stacchiotti
Poster
2016 ASCO Annual Meeting
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): Long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
First Author: Elena Palassini
Poster
2016 ASCO Annual Meeting
Tumor response assessment by Choi criteria in localized high-risk soft tissue sarcoma (STS) treated with chemotherapy (CT): Update at 10-year follow-up of an exploratory analysis on a phase III trial.
First Author: Silvia Stacchiotti